As of 1:00pm ET
| +0.125 / +5.88%|
The 4 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 7.50 and a low estimate of 2.00. The median estimate represents a +122.22% increase from the last price of 2.25.
The current consensus among 5 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.